Related Experiment Video
Updated: May 30, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
An immunomodulator in the treatment of schizophrenia : a double-blind study
S Agarwal1, A K Agarwal, S C Tewari
1Ex. Senior Resident, Department of Psychiatry, K.G's Medical College, Lucknow.
Abstract:
In a double blind study, the immunomodulator drug levamisole was administered along with chloropromazine to 18 schizophrenic patients, and efficiency of the combination was compared to that of chloropromazine along with placebo administered to 16 schizophrenic patients. The decrease in T suppressor cell count found in both groups at benchmark was found to be corrected in the patients receiving levamisole and this increase in T suppressor cell count was significantly correlated with the improvement in psychosis. The findings provide evidence in favour of the autoimmune hypothesis of schizophrenia.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drug Therapy
Antianxiety Medications
Schizophrenia
Psychosis and Antipsychotic Drugs: Overview
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Psychosis: Goals of Pharmacotherapy